Literature DB >> 9619261

Human factors in the health care facility.

D L Welch1.   

Abstract

Previous articles in this series have investigated the role of human factors engineering (HFE) in the design and development of medical devices and instrumentation. This article turns its focus to HFE within health care facilities--hospitals, clinics, nursing homes, HMOs, etc. The objective of HFE for the device manufacturer is to produce effective and safe systems. The health care facility is concerned with maintaining the safety of patients and staff, enhancing the cost efficiency of its operations, and controlling liability. Human factors engineering can be effective in realizing all of these goals. Proactive measures include (1) evaluation of currently employed systems for efficiency and error potential, (2) evaluation of systems prior to purchase, (3) evaluation and enhancement of facilities, and (4) design and evaluation of procedures. Retroactively, HFE participation in accident/incident investigations can carry such investigations beyond the placing of blame to determining what made a human error possible or even inevitable.

Entities:  

Mesh:

Year:  1998        PMID: 9619261

Source DB:  PubMed          Journal:  Biomed Instrum Technol        ISSN: 0899-8205


  4 in total

1.  Human factors engineering and patient safety.

Authors:  J Gosbee
Journal:  Qual Saf Health Care       Date:  2002-12

2.  Human factors engineering design demonstrations can enlighten your RCA team.

Authors:  J Gosbee; T Anderson
Journal:  Qual Saf Health Care       Date:  2003-04

3.  Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject.

Authors:  Stephanie Guerlain; Lu Wang; Akilah Hugine
Journal:  Ann Allergy Asthma Immunol       Date:  2010-12       Impact factor: 6.347

4.  A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference.

Authors:  Stephanie Guerlain; Akilah Hugine; Lu Wang
Journal:  Ann Allergy Asthma Immunol       Date:  2010-02       Impact factor: 6.347

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.